Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 641 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

Year : 2003  |  Volume : 14  |  Issue : 4  |  Page : 536-538
Profile of Patients with End-Stage Renal Disease (ESRD) in Jeddah

1 Department of Preventive Medicine, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
2 Department of Histopathology, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

Click here for correspondence address and email


To measure the prevalence of the most common causes of end-stage renal disease (ESRD) among patients on maintenance hemodialysis (MHD), we studied the records of 248 hemodialysis patients in the Jeddah Kidney Center in December 2000. We found that the majority of cases of ESRD were of unknown etiology (42.7%). Hypertension was the most common known cause (36.3%) followed by diabetes mellitus (14.5%). We conclude that hypertension and diabetes constitute the most frequently known causes of ESRD among hemodialyzed (HD) patients in the Jeddah region.

Keywords: Hypertension, Diabetes mellitus, End-Stage Renal Disease, Hemodialysis, Jeddah.

How to cite this article:
Al-Jiffri AY, Fadag RB. Profile of Patients with End-Stage Renal Disease (ESRD) in Jeddah. Saudi J Kidney Dis Transpl 2003;14:536-8

How to cite this URL:
Al-Jiffri AY, Fadag RB. Profile of Patients with End-Stage Renal Disease (ESRD) in Jeddah. Saudi J Kidney Dis Transpl [serial online] 2003 [cited 2022 Jan 26];14:536-8. Available from: https://www.sjkdt.org/text.asp?2003/14/4/536/32995

   Introduction Top

ESRD causes significant morbidity and mor­tality worldwide. [1] In Saudi Arabia, it appears to be one of the major medical problems. [2] This is perhaps attributable to environmental factors (temperature, humidity, rainfall); biological factors (infection, parasites); and socioeconomic conditions (urban and rural settlements, marital status, education, occu­pation). [3] In developed countries such as the USA, Europe, and Japan, the leading cause of ESRD has become diabetic nephropathy, particularly type II diabetes. [4],[5] Though less common in other countries, the percentage of ESRD patients with diabetes and hyper­tension is increasing. [1],[6]

In this study we attempt to assess the major causes of ESRD in our center .

   Methods Top

We studied the records of 248 patients on chronic dialysis in the Jeddeh Kidney Center, King Fahd Hospital Jeddah-Saudi Arabia, which is the referral dialysis center for most of the Western region in Saudi Arabia. A patient questionnaire was developed to collect data from the sample. Some of the data was collected by interview with patients.

   Results Top

A total of 248 patients were studied. The age of the patients ranged from 8-103 years, with a mean of 44 ± 15.6 years. There was predomi­nance of Saudi patients (67.3%) to non-Saudis (32.7%) and males (60%) to females (40%).

The duration on hemodialysis ranged from 2-240 months with a mean of 42 months. The etiology of ESRD could not be determined in 106 patients (42.7%) due to late referrals. Hypertension was the most frequent cause among patients with known etiology compri­sing 36.3% followed by diabetes mellitus (14.5%), [Table - 1].

   Discussion Top

The study shows that there was predomi­nance of males (60.1%) over females (39.9%) among hemodialysis patients, which is in accordance with the results of other studies conducted in Saudi Arabia. [7] as well as in other countries, including India (67.8% males and 32.2% females), [8] Japan (54.4% males and 45.6% females), [9] Qatar (54.5% males and 45.5% females), [10] Sudan (73.9% males and 26.1% females) [11] and Morocco (59% males and 41% females). [12]

This study also showed that there was pre­dominance of hemodialyzed Saudi patients (67.3%) over non-Saudi patients (32.7%). This is comparable to the studies carried out in Samtah (Gizan) [13] where Saudi patients comprised only 75.1%. In Madinah, [7] 71.3% were Saudis. Almost the same distribution of nationalities was recognized among the general population of Saudi Arabia where Saudis comprise 73%. [14] This indicates that there was proportional representation for the two groups at the hemodialysis center, which is similar to that in the general population. The differences in percentages among the sets of study data might be attributed to the higher proportion of non-Saudis in the population of Jeddah as compared to other regions in the Kingdom. [15]

The study shows that the most of ESRD patients at the hemodialysis center have unknown etiology (42.7%). A similar high percentage was also reported in Taif (KSA) (43.5%) [16] and Sudan (52%). [11] The European dialysis and transplantation association survey showed that unknown etiology was also high in Egypt, Algeria, Tunisia, Turkey, and Libya. [16] The most probable reason for this is the late presentation of patients in these countries, when diagnostic exploration is no longer possible. The most frequent known cause in the current study is hypertension (36.3%), which is emphasized by a study conducted in Gassim (KSA), which showed that systemic hypertension was the most common cause of ESRD in the region (47%). [17] In the United States, the Renal Diseases Annual Data Report of 1996 showed that hypertension was the second leading cause of ESRD accounting for 30.3%. [18] The second leading known cause of ESRD in our study was diabetes mellitus (type I & II) (14.5%); this was approximately the same as in studies carried out in Al-Hada hospital (KSA) (13.74%), [16] Kuwait (15%) [19] and Europe (13.1%). [16]

In conclusion, our study indicates that hyper­tension constitutes the most frequent known cause of ESRD (36.3%) followed by diabetes (14.5%) among hemodialyzed (HD) patients in the Jeddah region.

   Acknowledgment Top

The authors would like to express their thanks to the staff of the Jeddah Kidney Center.

   References Top

1.Al-Homrany M, Abolfotoh M. Incidence of treated end-stage renal disease in Asir region. Southern Saudi Arabia. Saudi J Kidney Dis Transplant 1998;9(4):425-9.  Back to cited text no. 1    
2.Akhtar M, Qunibi W, Saadi T, Furayh O, Sanjad S, Al-Sabban E. Spectrum of renal disease in Saudi Arabia. Ann Saudi Med 1990;10(1):37-44.  Back to cited text no. 2    
3.Ibrahim MA, Kordy MN. End-stage renal disease (ESRD) in Saudi Arabia. Asia Pac J Public Health 1992-93;6(3):140-5.  Back to cited text no. 3    
4.Odoni G, Ritz E. Diabetic nephropathy-­what have we learned in the last three decades? J Nephrol 1999;12(Suppl 2):S120-4.  Back to cited text no. 4  [PUBMED]  
5.Rossing P. Risk factors in the progression of diabetic nephropathies. Ugeskr Laeger 2000;162(38):5057-61.  Back to cited text no. 5    
6.Al-Muhanna FA, Saeed I, Al-Muelo S, Larbi E, Rubaish A. Disease profile, complications and outcome in patients on maintenance haemodialysis at King Fahd University Hospital, Saudi Arabia. East Afr Med J 1999;76(12):664-7.  Back to cited text no. 6    
7.Mitwalli AH, Al-Swailem A, Aziz KMS, et al. The incidence of end-stage renal disease in two regions of Kingdom of Saudi Arabia. Saudi J Kidney Dis Transplant 1995;6(3): 280-5.  Back to cited text no. 7    
8.Mittal S, Kher V, Gulati S, Agarwal LK, Arora P. Chronic renal failure in India. Ren Fail 1997;19(6):763-70.  Back to cited text no. 8    
9.Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996;49(3):800-5.  Back to cited text no. 9    
10.Rashid A, Abboud O, Taha M, El-Sayed M. Renal replacement therapy in Qatar. Saudi J Kidney Dis Transplant 1998;9(1):36-9.  Back to cited text no. 10    
11.Suliman S, Fessaha S, El Sadig M, et al. Prevalence of hepatitis C virus infection in hemodialysis patients in Sudan. Saudi J Kidney Dis Transplant 1995;6(2):154-6.  Back to cited text no. 11    
12.Amal B. Renal replacement therapy in Morocco. Saudi J Kidney Dis Transplant 1999;10(1):66-8.  Back to cited text no. 12    
13.Subramanian PT, Jamal A, Shaha MY. Hemodialysis utilization in a single in­center dialysis unit, in the Kingdom of Saudi Arabia. Saudi J Kidney Dis Transplant 2001;12(1):64-74.  Back to cited text no. 13    
14.Statistical yearbook. Central Department of Statistics, Ministry of Finance and National Economy, Kingdom of Saudi Arabia. 1992.  Back to cited text no. 14    
15.Al-Khader AA. Hepatitis C infection: the subject of this issue. Saudi J Kidney Dis Transplant 1995;6(2):115-7.  Back to cited text no. 15    
16.Hussien M, Mooij J, Roujouleh H, Bakir N. End-stage renal disease in Saudi Arabia: a single center study. Saudi J Kidney Dis Transplant 1991;2(2):79-84.  Back to cited text no. 16    
17.Soyannwo MA, Khan N, Kommajosyula S, et al. Hepatitis C antibodies in haemodialysis and pattern of end-stage renal failure in Gassim, Saudi Arabia. Afr J Med Med Sci 1996;25(1):13-22.  Back to cited text no. 17    
18.Mani MK. The etiology of end-stage renal disease: its implications for the patient and the profession. Saudi J Kidney Dis Transplant 1997;8(4):405-9.  Back to cited text no. 18    
19.El-Reshaid K. Renal replacement therapy in Kuwait. Saudi J Kidney Dis Transplant 1994;5(4):493-7.  Back to cited text no. 19    

Correspondence Address:
Abdullah Mohammed Y Al-Jiffri
King Fahd Armed Forces Hospital, P.O.Box 40332, Jeddah-21499
Saudi Arabia
Login to access the Email id

PMID: 17657131

Rights and Permissions


  [Table - 1]


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    Article Tables

 Article Access Statistics
    PDF Downloaded284    
    Comments [Add]    

Recommend this journal